Deep learning technology developer Netradyne has secured series A funding from Reliance Industries to help bring its products to market.

Pharmaceutical company CoSci Med-Tech led the round, which will help JDP Therapeutics advance a treatment for allergic reactions in hospitals through phase 3 trials.

Online budget hotel booking platform FabHotels has added series A funding to a seed round closed a year ago, Qualcomm having invested in both.

Logistics service GlobalTranz has spun out its freight tracking technology developer 10-4 Systems, with GlobalTranz co-founder Andrew Leto leading its series A round.

The UCL Technology Fund invests in gene therapy company Freeline, which hopes to treat blood diseases such as haemophilia B.

Auckland spinout StretchSense receives series A funding from Start Today, adding to an earlier investment from investors including the New Zealand Venture Investment Fund.

Minnesota University co-leads a series A round in its spinout, which is working on gene editing therapies.

Imperial Innovations has contributed to a series A round for small-molecule oncology treatment developer Storm Therapeutics, a Cambridge spinout.

E-commerce firm and existing investor Vente-Privee has returned to take part in another funding round for online flight booking startup MisterFly.